Spero Therapeutics, Inc. (NASDAQ:SPRO) Q2 2020 Earnings Conference Call August 6, 2020 4:30 PM ET Company Participants Sharon Klahre – Senior Director-Investor Relations Ankit Mahadevia – Co-Founder, President and Chief Executive Officer David Melnick – Chief Medical Officer Cristina Larkin – Chief Operating Officer Steve DiPalma – Interim Chief Financial Officer Conference Call Participants Ritu Baral – Cowen Louise Chen – Cantor Stephen Willey – Stifel Ram Selvaraju – H.C. Wainwright Chi Fong – Bank of Am ...